Fig. 5

Rp@Al-based prevention of MRSA-induced recurrent infections and improvement of the survival rate. a Schematic representation illustrating the prevention of MRSA-induced recurrent infections. Mice were injected s.c. with MRSA (10⁹ CFU, first exposure) followed by different treatments on Day 2. After 4 weeks, prevention of recurrent infections was evaluated by i.v. re-infection with MRSA (7.5 × 10⁸ CFU, second exposure). b Survival curve of mice in different treatment groups after i.v. re-infection with MRSA (n = 10). c–g Body weight monitoring of mice in different treatment groups after i.v. re-infection with MRSA (n = 10)